Supraspinal Contributions to the Control of Human Locomotion: Clinical and Fundamental Aspects

Post-stroke Gait Assessments Clinical Trial

— SUPLOCO  

Official title:

Supraspinal Contributions to the Control of Human Locomotion: Clinical and Fundamental Aspects

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02263560
• Other study ID #: UFribourg
• Status: Completed
• Phase: N/A
• First received: October 6, 2014
• Last updated: October 24, 2017
• Start date: March 2014
• Est. completion date: March 2016

Study information

• Verified date: October 2017
• Source: University of Fribourg
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Many neurological patients express enhanced deficits while walking in a dark room (or during the night): the supraspinal structures involved in this navigational deficit have not been identified yet. In this project, the investigators will study post-stroke gaits of human patients and compare them to those of a control population during a goal-oriented task performed in different visual conditions.

The investigators want to test the hypothesis that during simple goal-oriented locomotor tasks, only patients with specific (e.g. medio or infero- temporal) lesions will express navigational deficits.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: March 2016
• Est. primary completion date: January 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria (for matching controls):

• Adult male and female subjects (18-->85 years old)

Exclusion Criteria (for matching controls):

• Persons with history of an acquired or congenital neurological disorder, e.g. stroke, multiple sclerosis, Parkinson disease, increased intracranial pressure, etc.;

• Persons injured at the time of the experiments (fractures,…);

• Persons having reported repetitive spatial troubles/disorders;

• Persons with eye disorders and non-corrected vision problems;

• Pregnant women.

Related Conditions & MeSH terms

• Post-stroke Gait Assessments

Intervention

Behavioral:
• Kinematic measurements

Locations

Country	Name	City	State
Switzerland	University (UNIFR) and Hospital of Fribourg (HFR)	Fribourg

Sponsors (2)

Lead Sponsor	Collaborator
University of Fribourg	Dr Titus Bihl, Hopital Cantonal Fribourgeois

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Walking stability indices of post-stroke patients		1 hour and 30 minutes (including pre-tests, instructions delivery...).
Primary	Spatial accuracy of walking trajectories in post-stroke patients		1 hour and 30 minutes (including pre-tests, instructions delivery...).